The director of the Centers for Disease Control and Prevention, Rochelle Walensky, supports the expanded access of the Pfizer-BioNTech vaccine under 5 to 11 years of age in the United States, which has been applied since Tuesday. According to information published in Local 10.
The director of the Centers for Disease Control and Prevention, Rochelle Walensky, supports the expanded access of the Pfizer-BioNTech vaccine under 5 to 11 years of age in the United States, which has been applied since Tuesday. According to information published in Local 10.
He points out “we have seen how the educational gaps that exist in this country have widened, as this virus has disproportionately impacted racial and ethnic minority communities” and “pediatric vaccination has the power to help us change all that.” .
While Dr. Lee Beers, president of the American Academy of Pediatrics, issued a statement of support before CDC advisers voted 14-0 in favor of approval for the age group 5-11 years.
“Children need and deserve protection against COVID-19,” Beers wrote.
CDC and FDA experts agree that COVID-19 vaccines are safe and effective. The FDA authorized its use for the age group 5 to 11 years on October 29.
CDC advisers agreed that the vaccine offers more benefits than risks. Although fewer children have been infected than adults, minors can transmit the virus and some can become seriously ill.
